Hepatitis B Annual
Home

Current Issue  

Back Issues   

Instructions   

Search Login    Users online: 65 Print this page  Email this page Small font sizeDefault font sizeIncrease font size 
>>> Ahead of Print <<<
REVIEW ARTICLE
Year : 2009  |  Volume : 6  |  Issue : 1  |  Page : 29-40

Management of Hepatitis B in the peri-transplant period


1 Department of Gastroenterology and Hepatology, Sir Ganga Ram Hospital, New Delhi, India
2 Liver Transplantation, Sir Ganga Ram Hospital, New Delhi, India

Correspondence Address:
Sanjiv Saigal
Room No. 313, Department of Gastroenterology, Sir Ganga Ram Hospital, Rajinder Nagar, New Delhi-110 060
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0972-9747.76903

Rights and Permissions

Hepatitis B virus (HBV) infection is an important indication for liver transplantation worldwide. The most important concern is the prevention of viral recurrence in the post transplant period. With the introduction of Hepatitis B immunoglobulin, there has been a significance reduction in the rate of HBV recurrence with improved patient & graft survival rates. The combination of oral nucleosides along with Hepatitis B immunoglobulin has further reduced the rate of HBV recurrence, and currently the outcome of liver transplantation for HBV infection is comparable to other indications for liver transplantation.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed4294    
    Printed408    
    Emailed3    
    PDF Downloaded226    
    Comments [Add]    

Recommend this journal